Study of NP-101 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Undergoing Y-90 Treatment

Conditions: Hepatocellular Carcinoma Interventions: Drug: NP-101 Sponsors: University of Florida; Novatek Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials